サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629330

腎除神経デバイスの世界市場：技術別、製品別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2025年～2032年）

Renal Denervation Devices Market, By Technology, By Product, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
腎除神経デバイスの世界市場：技術別、製品別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2025年～2032年）
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

腎除神経デバイス市場規模は2024年に2億5,109万米ドルとなり、2025年から2032年にかけてCAGR 40.98%で拡大

腎除神経デバイス市場 - 市場力学

高血圧の有病率の上昇

腎除神経デバイス市場は、高血圧の有病率の上昇により、今後の発展が期待されます。動脈を流れる血液の力が継続的に高すぎる場合、それは高血圧または高血圧と呼ばれます。抵抗性高血圧の患者には、カテーテルを用いた腎除神経術が有効な治療選択肢となっています。薬では改善しない高血圧に対して、低侵襲で実験的な治療法が腎除神経です。例えば、2023年1月、米国ミシシッピ州の保健局（Mississippi State Department of Health）は、2021年に約100万人の成人ミシシッピ人（43.9％）が高血圧であると報告しました。2021年のMSの高血圧有病率は米国より36.3％高かったです（MS：43.9％、米国：32.2％）。したがって、腎除神経デバイスの市場は、高血圧の罹患率の上昇の結果として拡大すると思われます。

腎除神経デバイス市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025年～2032年）に約40.98％のCAGRで毎年成長すると推定されます。

技術セグメンテーションに基づくと、高周波アブレーションが2024年に最大市場シェアを示すと予測されました。

エンドユーザーセグメンテーションに基づくと、2024年には病院が主要セグメントとなりました。

地域別では、北米が2024年の売上高でトップでした。

腎除神経デバイス市場 - セグメンテーション分析：

腎除神経デバイスの世界市場は、技術、製品、エンドユーザー、地域に基づいてセグメント化されます。

技術別では、市場は高周波アブレーション、ブラキセラピー、超音波エネルギーベースのRDN、化学アブレーション、その他に分別されます。2024年、市場は高周波アブレーションのカテゴリーが支配的でしたが、その理由は確立された市場プレゼンスと、この技術を用いた手術の成功件数の多さです。開始以来広く利用されているこの技術は、高周波エネルギーを用いて亢進した腎神経を破壊します。例えば、インドのカウベリー病院は2024年5月、持続性高血圧に対する高周波に基づく新しい腎除神経治療を導入しました。インド政府が承認したこの技術は、神経活動を低下させ、重度の薬剤抵抗性高血圧の治療において有望な結果を示し、この技術が市場をリードしていることを浮き彫りにしました。

エンドユーザーに基づき、市場は病院、診療所、心臓血管研究所、その他に分けられます。2024年時点では、洗練されたインフラ、高度に熟練した人材、複雑なプロセスに対応するリソースを有する病院のカテゴリーが圧倒的な市場シェアを占めています。患者が最先端の治療を受けやすいように、診療報酬体系や支援医療政策が確立されているため、これらの施設は抵抗性高血圧の症例の取り扱いに非常に成功しています。病院は、本来の業務に加えて、新しい腎除神経療法の安全性と有効性を評価する臨床試験にも不可欠です。このような調査によって、この分野は進歩し、新しいツールや方法を標準的な医療行為に早期に取り入れることにも役立っています。これらの研究機関は、臨床試験に積極的に参加し、エビデンスに基づいた治療法の開発を支援することで、高血圧患者の治療レジメンを強化しています。

腎除神経デバイス市場 - 地理的洞察

2024年、北米が腎除神経デバイス業界をリードしていますが、その主な理由は、大幅な技術進歩とFDAの承認要請の多さです。2023年、FDAは「シンプリシティスパイラルシステムとパラダイス超音波装置」を米国における2つの腎除神経デバイスの1つとして認可しました。さらに、この地域の優位性は、高齢化、ライフスタイルの変化、高血圧の高い有病率など、多くの要因に起因しています。市場の成長は、効率的な機器を製造するための研究開発努力の増加も主な要因となっています。現地での新発売の増加も、腎除神経デバイス市場の成長を後押ししている側面です。

腎除神経デバイスの市場は、処置の長期的な効果、高血圧率の上昇、技術の進歩の増加などの要因により、欧州で大きく発展すると予想されています。例えば、Office of Health Improvement and Disparitiesのデータによると、イングランドでは2021年に8,457,600人が高血圧症でした。さらに、2021年にイタリアで行われた調査では、回答者の73.6％が自分の血圧を自覚していると答え、42.3％が高血圧と診断され、41.4％が降圧剤を服用していると答えました。さらに、男性は女性よりも高血圧であると自己申告する傾向が強かった。その結果、この地域の拡大の主な原因の1つは、高血圧の有病率の上昇です。

腎除神経デバイス市場 - 競合情勢：

異なる市場参入企業間の熾烈な敵対関係が、世界の腎除神経デバイス市場の競合環境の特徴です。大規模な業界参加者は、Medtronic PLC、ReCor Medical Inc.（Otsuka Holdings Co. Ltd）、St. Jude Medical Inc.（Abbott Laboratories）、Symple Surgical Inc.、Ablative Solutions Inc.、Covidien PLC、Mercator MedSystems Inc.など、世界の足跡を強化するために多くの戦術を積極的に追求しています。さらに、多くの医療機器メーカー、研究機関、ヘルスケアプロバイダーが、腎除神経デバイスの新規技術や治療戦略を提供するために市場に参入しています。パートナーシップや共同研究、研究開発イニシアティブを通じて、これらの企業はこの分野のさらなる発展に尽力しています。さらに、製品の革新は腎除神経デバイス市場でますます普及しつつある大きな動向です。腎除神経デバイス市場の大手企業は、自社の地位を向上させ、競合優位性を獲得するために、最先端の商品を生み出すことに注力しています。例えば、米国の医療機器メーカーであるReCor Medical Inc.は、2021年10月に高血圧治療のためのパラダイス超音波腎除神経システムを発表しました。非焦点超音波を使用するこの技術は、腎臓に向かう過活動神経を低侵襲で治療します。偽手術と比較した場合、パラダイスシステムは血圧降下に成功することが実証されています。

最近の動向

2024年6月：韓国のソウルに本社を置く医療機器事業会社DeepQure Inc.は、FDAから実験的機器免除を承認され、現在HyperQure腎除神経（RDN）システムの早期実現可能性試験（EFS）を開始していると発表しました。抵抗性高血圧の治療のため、RDNは血管外腹腔鏡ツールHyperQureを使用します。

2024年4月：Recor Medical, Inc.とその親会社であるOtsuka Medical Devices Co., Ltd.が発表した声明によると、FDAはパラダイス超音波腎除神経システムを承認しました。現在市販されているこの最先端技術は、最近アラブ首長国連邦のシャルジャにあるアル・カシミ病院で中東市場に導入されました。このパラダイスシステムは、最先端の超音波技術を用いて、亢進した腎ニューロンを標的として遮断することで、抵抗性高血圧の治療に画期的なアプローチを提供します。

2023年11月：米国の医療機器メーカーRecor Medical社がパラダイス超音波腎除神経療法を発表。超音波技術を用いて腎動脈周囲の交感神経を脱神経させるもので、米国で初めてFDAが承認した腎脱神経療法です。これにより、高血圧の原因となる過活動が軽減されます。高血圧管理における待望の画期的治療法として、パラダイスシステムは臨床試験で顕著な血圧低下を実証しています。

目次

第1章 腎除神経デバイス市場の概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 腎除神経デバイスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 腎除神経デバイス産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 腎除神経デバイス市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 腎除神経デバイスの市場情勢

  • 腎除神経デバイスの市場シェア分析、2024年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 腎除神経デバイス市場 - 技術別

  • 概要
    • セグメントシェア分析 - 技術別
    • 高周波アブレーション
    • 近接放射線療法
    • 超音波エネルギーベースのRDN
    • 化学アブレーション
    • その他

第8章 腎除神経デバイス市場 - 製品別

  • 概要
    • セグメントシェア分析 - 製品別
    • 単一電極
    • マルチ電極
    • 非灌流カテーテル
    • 灌流カテーテル
    • その他

第9章 腎除神経デバイス市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析 - エンドユーザー別
    • 病院
    • クリニック
    • 心臓血管研究センター
    • その他

第10章 腎除神経デバイス市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 腎除神経デバイス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Medtronic PLC
    • ReCor Medical Inc.（Otsuka Holdings Co. Ltd）
    • St. Jude Medical Inc.（Abbott Laboratories）
    • Symple Surgical Inc.
    • Ablative Solutions Inc.
    • Covidien PLC
    • Mercator MedSystems Inc.
    • Terumo Corporation
    • Kona Medical Inc.
    • Vessix Vascular Inc.（Boston Scientific Corporation）
    • Renal Dynamics Limited
    • DeepQure
    • Johnson &Johnson Private Limited
    • Miracor Medical SA
    • SoniVie（CardioSonic, Inc.）
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4515

REPORT HIGHLIGHT

Renal Denervation Devices Market size was valued at US$ 251.09 Million in 2024, expanding at a CAGR of 40.98% from 2025 to 2032.

A minimally invasive technique called renal denervation attempts to reduce the sympathetic nervous system's activity in the kidneys. A catheter is inserted via the arteries and into the renal arteries, which provide blood to the kidneys. The gadget then sends electricity to the vessel wall's nerves to interfere with the signals that can lead to hypertension. There are several ways to provide the energy, including radiofrequency ablation, ultrasound, and, more recently, chemical injections directly or novel techniques based on percutaneous delivery systems. The growing prevalence of hypertension is one of several factors driving the market's expansion. Furthermore, during the projected period, the renal denervation devices market is anticipated to rise as a result of the growing acceptance of innovative goods. For instance, the medical device business Kalos Medical was awarded Won4.67m (about $3.5m) to develop further their renal denervation medical device for the treatment of hypertension. Technological advancements in renal denervation (RDN) products, the growing elderly population, the short-term and permanent effects of renal denervation procedures, and the rising incidence of uncontrolled and treatment-resistant or drug-resistant hypertension (trHTN) are additional factors propelling the renal denervation devices market growth.

Renal Denervation Devices Market- Market Dynamics

Rising Prevalence of Hypertension

The market for renal denervation devices is anticipated to develop in the future due to the rising prevalence of hypertension. When the force of blood flowing through the blood arteries is continuously too high, it is referred to as hypertension or high blood pressure. For patients with resistant hypertension, renal denervation-a catheter-based procedure-has become a viable treatment option. A minimally invasive, experimental treatment for hypertension that has not improved with medicines is renal denervation. For instance, in January 2023, the Mississippi State Department of Health, a Mississippi state health department situated in the United States, reported that approximately 1 million adult Mississippians (43.9%) had high blood pressure in 2021. The prevalence of hypertension was 36.3% greater in MS in 2021 than in the US (MS: 43.9%, US: 32.2%). Thus, the market for renal denervation devices will expand as a result of the rising incidence of hypertension.

Renal Denervation Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.98% over the forecast period (2025-2032)

Based on technology segmentation, radio frequency ablation was predicted to show maximum market share in the year 2024

Based on end-user segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Renal Denervation Devices Market- Segmentation Analysis:

The Global Renal Denervation Devices Market is segmented on the basis of Technology, Product, End-user, and Region.

On the basis of technology, the market is segregated into Radio Frequency Ablation, Brachytherapy, Ultrasound Energy-based RDN, Chemical Ablation, and Others. In 2024, the market was dominated by the radio frequency ablation category because of its established market presence and the large number of successful surgeries carried out using this technology. This technique, which has been widely used since its inception, uses radiofrequency energy to break up hyperactive renal nerves. For instance, Kauvery Hospital in India introduced a novel renal denervation treatment based on radiofrequency for persistent hypertension in May 2024. The Indian government-approved technique demonstrated promising outcomes in lowering nerve activity and treating severe, drug-resistant hypertension, highlighting the technology's market leadership.

Based on end-user, the market is divided into Hospitals, Clinics, Cardiovascular research centre, and Others. In 2024, the hospitals category held a dominant market share because of their sophisticated infrastructure, highly skilled personnel, and resources for intricate processes. Due to well-established reimbursement structures and supportive healthcare policies that make it easier for patients to receive state-of-the-art therapies, these facilities are very successful at handling cases of resistant hypertension. Hospitals are essential for clinical trials that assess the safety and effectiveness of novel renal denervation therapies, in addition to their core duties. The field is advanced by this research, which also aids in the early integration of novel tools and methods into standard medical practice. These institutes enhance treatment regimens for hypertension patients by actively engaging in trials and helping to develop evidence-based procedures.

Renal Denervation Devices Market- Geographical Insights

In 2024, North America led the renal denervation devices industry, mostly due to significant technological advancements and a high amount of FDA approval requests. In 2023, the FDA authorized the "Symplicity Spyral System and Ultrasound-based Paradise Device" as one of two renal denervation devices in the US. Furthermore, the region's dominance is attributed to a number of factors, including an ageing population, changing lifestyles, and the high prevalence of hypertension. The market's growth is also primarily driven by increasing R&D efforts to produce efficient devices. The rise in local new launches is another aspect propelling the renal denervation devices market's growth.

The market for renal denervation devices is anticipated to develop significantly in Europe due to factors like the procedure's long-lasting effects, rising rates of hypertension, and increased technological advancements. For instance, according to data from the Office of Health Improvement and Disparities, 8,457,600 people in England had hypertension in 2021. Furthermore, 73.6% of respondents to a survey done in Italy in 2021 said they were aware of their blood pressure, 42.3% said they had been diagnosed with hypertension, and 41.4% said they were taking antihypertensive drugs. Additionally, men were more likely than women to self-report having hypertension. Consequently, one of the main causes of the region's expansion is the rising prevalence of hypertension.

Renal Denervation Devices Market- Competitive Landscape:

The fierce rivalry between different industry participants is a defining feature of the competitive environment of the worldwide renal denervation devices market. Large industry participants are aggressively pursuing a number of tactics to bolster their worldwide footprint, including Medtronic PLC, ReCor Medical Inc. (Otsuka Holdings Co. Ltd), St. Jude Medical Inc. (Abbott Laboratories), Symple Surgical Inc., Ablative Solutions Inc., Covidien PLC, Mercator MedSystems Inc., and others. Furthermore, numerous medical device makers, research institutes, and healthcare providers are participating in the market in an effort to provide novel technologies and treatment strategies for renal denervation devices. Through partnerships, collaborations, and research and development initiatives, these players are committed to furthering the area. Additionally, product innovation is a major trend that is becoming more and more popular in the market for renal denervation devices. Large firms in the market for renal denervation devices are concentrating on creating cutting-edge goods to improve their standing and obtain a competitive edge. For instance, ReCor Medical Inc., a US-based manufacturer of medical devices, introduced the Paradise Ultrasound Renal Denervation System in October 2021 to treat hypertension. Using non-focused ultrasound, this technique treats hyperactive nerves that go to the kidney in a less invasive manner. When compared to a sham operation, the Paradise System has been demonstrated to lower blood pressure successfully.

Recent Development

June 2024: DeepQure Inc., a medical device business based in Seoul, South Korea, stated that it has approved an experimental device exemption from the FDA and is now beginning an early feasibility study (EFS) for the HyperQure renal denervation (RDN) system. For the treatment of resistant hypertension, RDN uses the extravascular laparoscopic tool HyperQure.

April 2024: The FDA has approved the paradise ultrasound renal denervation system, according to a statement released by Recor Medical, Inc. and its parent firm, Otsuka Medical Devices Co., Ltd. This cutting-edge technology, which is currently on the market, was recently introduced to the Middle Eastern market at Al Qassimi Hospital in Sharjah, United Arab Emirates. The Paradise system offers a revolutionary approach to treating resistant hypertension by using cutting-edge ultrasound technology to target and interrupt hyperactive renal neurons.

November 2023: The US-based medical equipment business Recor Medical introduced Paradise Ultrasound Renal Denervation Therapy. The sympathetic nerves around the renal arteries are denervated utilizing ultrasound technology, which is the first FDA-approved renal denervation therapy in the US. This reduces the overactivity that can cause hypertension. As a much-needed breakthrough in the management of hypertension, the Paradise System has demonstrated notable drops in blood pressure in clinical testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RENAL DENERVATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic PLC
  • ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
  • St. Jude Medical Inc. (Abbott Laboratories)
  • Symple Surgical Inc.
  • Ablative Solutions Inc.
  • Covidien PLC
  • Mercator MedSystems Inc.
  • Terumo Corporation
  • Kona Medical Inc.
  • Vessix Vascular Inc. (Boston Scientific Corporation)
  • Renal Dynamics Limited
  • DeepQure
  • Johnson & Johnson Private Limited
  • Miracor Medical SA
  • SoniVie (CardioSonic, Inc.)
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Radio Frequency Ablation
  • Brachytherapy
  • Ultrasound Energy-based RDN
  • Chemical Ablation
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Single electrode
  • Multi Electrode
  • Non irrigated catheter
  • Irrigated Catheter
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Cardiovascular research centre
  • Others

GLOBAL RENAL DENERVATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Renal Denervation Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Renal Denervation Devices Market Snippet by Technology
    • 2.1.2. Renal Denervation Devices Market Snippet by Product
    • 2.1.3. Renal Denervation Devices Market Snippet by End-user
    • 2.1.4. Renal Denervation Devices Market Snippet by Country
    • 2.1.5. Renal Denervation Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Renal Denervation Devices Key Market Trends

  • 3.1. Renal Denervation Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Renal Denervation Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Renal Denervation Devices Market Opportunities
  • 3.4. Renal Denervation Devices Market Future Trends

4. Renal Denervation Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Renal Denervation Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Renal Denervation Devices Market Landscape

  • 6.1. Renal Denervation Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Renal Denervation Devices Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Radio Frequency Ablation
    • 7.1.3. Brachytherapy
    • 7.1.4. Ultrasound Energy-based RDN
    • 7.1.5. Chemical Ablation
    • 7.1.6. Others

8. Renal Denervation Devices Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 8.1.2. Single electrode
    • 8.1.3. Multi Electrode
    • 8.1.4. Non irrigated catheter
    • 8.1.5. Irrigated Catheter
    • 8.1.6. Others

9. Renal Denervation Devices Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Cardiovascular research centre
    • 9.1.5. Others

10. Renal Denervation Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Renal Denervation Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Renal Denervation Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Renal Denervation Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Renal Denervation Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Renal Denervation Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Renal Denervation Devices Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Medtronic PLC
    • 11.2.2. ReCor Medical Inc. (Otsuka Holdings Co. Ltd)
    • 11.2.3. St. Jude Medical Inc. (Abbott Laboratories)
    • 11.2.4. Symple Surgical Inc.
    • 11.2.5. Ablative Solutions Inc.
    • 11.2.6. Covidien PLC
    • 11.2.7. Mercator MedSystems Inc.
    • 11.2.8. Terumo Corporation
    • 11.2.9. Kona Medical Inc.
    • 11.2.10. Vessix Vascular Inc. (Boston Scientific Corporation)
    • 11.2.11. Renal Dynamics Limited
    • 11.2.12. DeepQure
    • 11.2.13. Johnson & Johnson Private Limited
    • 11.2.14. Miracor Medical SA
    • 11.2.15. SoniVie (CardioSonic, Inc.)
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us